Emerging talents in frontiers in pharmacology: pharmacogenetics and pharmacogenomics 2022

被引：0
作者：
Klomp, Sylvia D. [1 ]
Alfirevic, Ana [2 ]
机构：
[1] Leiden Univ, Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands
[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool, England
来源：
FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷
关键词：
pharmacogenetics; pharmacogenomics; early career researcher; publications; future; HERITABILITY;
D O I：
10.3389/fphar.2023.1307602
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 10 条
  • [1] A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations
    Bank, Paul C. D.
    Swen, Jesse J.
    Guchelaar, Henk-Jan
    [J]. PHARMACOGENOMICS, 2017, 18 (03) : 215 - 225
  • [2] Klein Kathrin, 2013, Frontiers in Genetics, V4, P12, DOI 10.3389/fgene.2013.00012
  • [3] Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
    Klomp, Sylvia D.
    Manson, Martijn L.
    Guchelaar, Henk-Jan
    Swen, Jesse J.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 33
  • [4] Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing
    Lauschke, Volker M.
    Ingelman-Sundberg, Magnus
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 130 : 65 - 77
  • [5] Cytochrome P450 Structure, Function and Clinical Significance: A Review
    Manikandan, Palrasu
    Nagini, Siddavaram
    [J]. CURRENT DRUG TARGETS, 2018, 19 (01) : 38 - 54
  • [6] Heritability of Metoprolol and Torsemide Pharmacokinetics
    Matthaei, J.
    Brockmoeller, J.
    Tzvetkov, M. V.
    Sehrt, D.
    Sachse-Seeboth, C.
    Hjelmborg, J. B.
    Moeller, S.
    Halekoh, U.
    Hofmann, U.
    Schwab, M.
    Kerb, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (06) : 611 - 621
  • [7] Addressing phenoconversion: the Achilles' heel of personalized medicine
    Shah, Rashmi R.
    Smith, Robert L.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (02) : 222 - 240
  • [8] A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
    Swen, Jesse J.
    van der Wouden, Cathelijne H.
    Manson, Lisanne E. N.
    Abdullah-Koolmees, Heshu
    Blagec, Kathrin
    Blagus, Tanja
    Boehringer, Stefan
    Cambon-Thomsen, Anne
    Cecchin, Erika
    Cheung, Ka-Chun
    Deneer, Vera H. M.
    Dupui, Mathilde
    Ingelman-Sundberg, Magnus
    Jonsson, Siv
    Joefield-Roka, Candace
    Just, Katja S.
    Karlsson, Mats O.
    Konta, Lidija
    Koopmann, Rudolf
    Kriek, Marjolein
    Lehr, Thorsten
    Mitropoulou, Christina
    Rial-Sebbag, Emmanuelle
    Rollinson, Victoria
    Roncato, Rossana
    Samwald, Matthias
    Schaeffeler, Elke
    Skokou, Maria
    Schwab, Matthias
    Steinberger, Daniela
    Stingl, Julia C.
    Tremmel, Roman
    Turner, Richard M.
    van Rhenen, Mandy H.
    Fajardo, Cristina L. Davila
    Dolzan, Vita
    Patrinos, George P.
    Pirmohamed, Munir
    Sunder-Plassmann, Gere
    Toffoli, Giuseppe
    Guchelaar, Henk-Jan
    [J]. LANCET, 2023, 401 (10374) : 347 - 356
  • [9] Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data
    van der Lee, Maaike
    Allard, William G.
    Vossen, Rolf H. A. M.
    Baak-Pablo, Renee F.
    Menafra, Roberta
    Deiman, Birgit A. L. M.
    Deenen, Maarten J.
    Neven, Patrick
    Johansson, Inger
    Gastaldello, Stefano
    Ingelman-Sundberg, Magnus
    Guchelaar, Henk-Jan
    Swen, Jesse J.
    Anvar, Seyed Yahya
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (603)
  • [10] Zanger UM, 2018, ADV PHARMACOL, V83, P33, DOI 10.1016/bs.apha.2018.02.003
1